SCHEMBL13352146

SCHEMBL13352146

CCOc1cc(/C=C/C(=O)Nc2ccccc2C=O)ccc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
HPGD P15428 4/20 0.60
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
KDM4E B2RXH2 3/20 0.60
TP53 P04637 2/20 0.60
CYP3A4 P08684 2/20 0.60
HIF1A Q16665 2/20 0.60
PKM P14618 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
HSD17B10 Q99714 1/20 0.60
ABCC4 O15439 1/20 0.60
HPGDS O60760 1/20 0.60
ABCB11 O95342 1/20 0.60
ALOX12 P18054 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13352093 0.96 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL14319164 0.92 MEN1 (0.58) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL13352244 0.91 MEN1 (0.71) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL13352097 0.91 MEN1 (0.57) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL9607108 0.89 CNR2 (0.58) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL14021036 0.88 MEN1 (0.54) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL13352143 0.88 PKM (0.57) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL14021144 0.87 SMN1; SMN2 (0.55) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL14021155 0.87 BCHE (0.59) ALDH1A1MEN1KMT2AHPGDNPC1
SCHEMBL14021147 0.86 MEN1 (0.52) ALDH1A1MEN1KMT2AHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130497-A1 Therapeutic Compounds FIBROTECH THERAPEUTICS PTY LTD (AU) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130497-A1 Therapeutic Compounds NFATC1, NAT1, AADAC ALDH1A1 199/4885MEN1 2640/4885KMT2A 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.